This is a Validated Antibody Database (VAD) review about human TNFRSF11A, based on 7 published articles (read how Labome selects the articles), using TNFRSF11A antibody in all methods. It is aimed to help Labome visitors find the most suited TNFRSF11A antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
TNFRSF11A synonym: CD265; FEO; LOH18CR1; ODFR; OFE; OPTB7; OSTS; PDB2; RANK; TRANCER; tumor necrosis factor receptor superfamily member 11A; Paget disease of bone 2; loss of heterozygosity, 18, chromosomal region 1; osteoclast differentiation factor receptor; receptor activator of NF-KB; receptor activator of nuclear factor-kappa B; tumor necrosis factor receptor superfamily, member 11a, NFKB activator

Abcam
mouse monoclonal (64C1385)
  • flow cytometry; human; 1:50; loading ...; fig 1b
  • flow cytometry; mouse; 1:50; fig 1b
Abcam TNFRSF11A antibody (Abcam, ab13918) was used in flow cytometry on human samples at 1:50 (fig 1b) and in flow cytometry on mouse samples at 1:50 (fig 1b). Bone Res (2018) ncbi
rabbit polyclonal
  • western blot; scFv; 1:800; loading ...; fig 1c
Abcam TNFRSF11A antibody (Abcam, ab200369) was used in western blot on scFv samples at 1:800 (fig 1c). Bone Res (2018) ncbi
mouse monoclonal (64C1385)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 1a
Abcam TNFRSF11A antibody (Abcam, AB13918) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1a). Oral Surg Oral Med Oral Pathol Oral Radiol (2015) ncbi
R&D Systems
mouse monoclonal (80704)
  • flow cytometry; human; loading ...; fig 1e, 1f
In order to study the involvement of RANKL in decidual M2 macrophage polarization, R&D Systems TNFRSF11A antibody (R&D Systems, FAB683P) was used in flow cytometry on human samples (fig 1e, 1f). Cell Death Dis (2017) ncbi
mouse monoclonal (80704)
  • immunohistochemistry - paraffin section; human
R&D Systems TNFRSF11A antibody (R&D Systems, MAB683) was used in immunohistochemistry - paraffin section on human samples . Clin Breast Cancer (2015) ncbi
Novus Biologicals
mouse monoclonal (9A725)
  • western blot; mouse; fig 4
In order to analyze osteoclasts and its regulatory extracellular vesicles, Novus Biologicals TNFRSF11A antibody (Novus Biologicals, NB100-56508) was used in western blot on mouse samples (fig 4). J Dent Res (2016) ncbi
Santa Cruz Biotechnology
mouse monoclonal (9A725)
  • immunohistochemistry - paraffin section; human; 1:500; fig 1
Santa Cruz Biotechnology TNFRSF11A antibody (santa Cruz, sc-52951) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1). Oncotarget (2015) ncbi
Invitrogen
mouse monoclonal (9A725)
  • flow cytometry; mouse; fig 5
In order to analyze modulation of osteoclast formation in metaphyseal bone by chondrocytes-specific expression iof osteoprotegerin, Invitrogen TNFRSF11A antibody (Thermo Fisher Scientific, 9A725) was used in flow cytometry on mouse samples (fig 5). Sci Rep (2015) ncbi
Articles Reviewed
  1. Chen X, Zhi X, Wang J, Su J. RANKL signaling in bone marrow mesenchymal stem cells negatively regulates osteoblastic bone formation. Bone Res. 2018;6:34 pubmed publisher
  2. Meng Y, Zhou W, Jin L, Liu L, Chang K, Mei J, et al. RANKL-mediated harmonious dialogue between fetus and mother guarantees smooth gestation by inducing decidual M2 macrophage polarization. Cell Death Dis. 2017;8:e3105 pubmed publisher
  3. Huynh N, VonMoss L, Smith D, Rahman I, Felemban M, Zuo J, et al. Characterization of Regulatory Extracellular Vesicles from Osteoclasts. J Dent Res. 2016;95:673-9 pubmed publisher
  4. Wang B, Jin H, Shu B, Mira R, Chen D. Chondrocytes-Specific Expression of Osteoprotegerin Modulates Osteoclast Formation in Metaphyseal Bone. Sci Rep. 2015;5:13667 pubmed publisher
  5. Zhang L, Teng Y, Fan Y, Wang Y, Li W, Shi J, et al. The E3 ubiquitin ligase Cbl-b improves the prognosis of RANK positive breast cancer patients by inhibiting RANKL-induced cell migration and metastasis. Oncotarget. 2015;6:22918-33 pubmed
  6. Siar C, Tsujigiwa H, Ishak I, Hussin N, Nagatsuka H, Ng K. RANK, RANKL, and OPG in recurrent solid/multicystic ameloblastoma: their distribution patterns and biologic significance. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;119:83-91 pubmed publisher
  7. Labovsky V, Martinez L, Davies K, Garcia Rivello H, Calcagno M, Matas A, et al. Association between ligands and receptors related to the progression of early breast cancer in tumor epithelial and stromal cells. Clin Breast Cancer. 2015;15:e13-21 pubmed publisher